Clinical significance of extrapancreatic lesions in autoimmune pancreatitis

Pancreas

Volumn 39, Issue 1, 2010, Pages

  Naitoh, Itaru ^a   Nakazawa, Takahiro ^a   Ohara, Hirotaka ^a   Ando, Tomoaki ^a   Hayashi, Kazuki ^a   Tanaka, Hajime ^a   Okumura, Fumihiro ^a   Miyabe, Katsuyuki ^a   Yoshida, Michihiro ^a   Sano, Hitoshi ^b   Takada, Hiroki ^c   Joh, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c Kasugai Municipal Hospital   (Japan)

Author keywords

Autoimmune pancreatitis; Extrapancreatic lesion; Relapse; Sclerosing sialadenitis

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PREDNISOLONE;

ADULT; AGED; ANAPHYLACTOID PURPURA; ANEURYSM; AORTA ANEURYSM; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG DOSE INCREASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HYPOTHYROIDISM; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL NEPHRITIS; INTERSTITIAL PNEUMONIA; LYMPHADENOPATHY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; OBSTRUCTIVE JAUNDICE; PANCREAS DUCT STENOSIS; PERCEPTION DEAFNESS; PREDICTOR VARIABLE; PRIORITY JOURNAL; RELAPSE; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SIALOADENITIS; UNIVARIATE ANALYSIS;

AGED; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; IMMUNOGLOBULIN G; LOGISTIC MODELS; LYMPHATIC DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDIES; SIALADENITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74049119392     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bd64a1     Document Type: Article

References (23)

1. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Dig Dis Sci. 1995;40:1561-1568.
2. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
3. Hirano K, Kawabe T, Yamamoto N, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta. 2006;367: 181-184.
4. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas. 2004;29:167-168.
5. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23-28.
6. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28: 1193-1203.
7. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003; 52:683-687.
8. Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphoadenopathy. Pancreatology. 2006;6:132-137.
9. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002; 359:1403-1404.
10. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003; 38:982-984.
11. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016.
12. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12: 2487-2496.
13. Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197-1205.
14. Kamisawa T, Egawa N, Nakajima H, et al. Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol. 2005;39:904-907.
15. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719-1724.
16. Kubota K, Iida H, Fuzisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142-1151.
17. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQA1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134:440-446.
18. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41: 626-631.
19. Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.
20. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937-944.
21. Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009. In press.
22. Kamisawa T, Imai M, Egawa N, et al. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2008;20:1167-1170.
23. Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16-21.